Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet

Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet

Background: The high consumption of fat and sugar contributes to the development of obesity and co-morbidities, such as diabetes, and cardiovascular and kidney diseases. Different strategies have been used to prevent these diseases associated with obesity, such as changes in eating habits and/or the...

Full description

Bibliographic Details
Main Authors: Fabiane Valentini Francisqueti, Igor Otávio Minatel, Artur Junio Togneri Ferron, Silméia Garcia Zanati Bazan, Vanessa dos Santos Silva, Jéssica Leite Garcia, Dijon Henrique Salomé de Campos, Ana Lúcia Ferreira, Fernando Moreto, Antonio Carlos Cicogna, Camila Renata Corrêa
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Nutrients
Subjects:
high sugar-fat diet
obesity
cardiac dysfunction
renal disease
gamma-oryzanol
Cardiorenal Metabolic Syndrome
Online Access:https://www.mdpi.com/2072-6643/9/12/1299

Internet

https://www.mdpi.com/2072-6643/9/12/1299

Similar Items